Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,727 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuromuscular transmission deficits in patients with CMT and ClC-1 inhibition in CMT animal models.
Grønnebæk TS, Haahr-Lillevang H, Skov M, Kelly K, Kerr NR, Viteri JA, Jaworek A, Bartlett A, Bold J, Hutchison J, Quiroz J, Tankisi H, Pedersen TH, Andersen H, Arnold WD. Grønnebæk TS, et al. Among authors: kelly k. Ann Clin Transl Neurol. 2024 Dec 13. doi: 10.1002/acn3.52252. Online ahead of print. Ann Clin Transl Neurol. 2024. PMID: 39670429 Free article.
Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.
LoRusso S, Johnson NE, McDermott MP, Eichinger K, Butterfield RJ, Carraro E, Higgs K, Lewis L, Mul K, Sacconi S, Sansone VA, Shieh P, van Engelen B, Wagner K, Wang L, Statland JM, Tawil R; ReSolve Investigators and the FSHD CTRN18. LoRusso S, et al. BMC Neurol. 2019 Sep 10;19(1):224. doi: 10.1186/s12883-019-1452-x. BMC Neurol. 2019. PMID: 31506080 Free PMC article.
Safety, Tolerability, and Effect of Nusinersen Treatment in Ambulatory Adults With 5q-SMA.
Elsheikh B, Severyn S, Zhao S, Kline D, Linsenmayer M, Kelly K, Tellez M, Bartlett A, Heintzman S, Reynolds J, Sterling G, Weaver T, Rajneesh K, Kolb SJ, Arnold WD. Elsheikh B, et al. Among authors: kelly k. Front Neurol. 2021 May 20;12:650535. doi: 10.3389/fneur.2021.650535. eCollection 2021. Front Neurol. 2021. PMID: 34093395 Free PMC article.
Persistent neuromuscular junction transmission defects in adults with spinal muscular atrophy treated with nusinersen.
Arnold WD, Severyn S, Zhao S, Kline D, Linsenmayer M, Kelly K, Tellez M, Bartlett A, Heintzman S, Reynolds J, Sterling G, Weaver T, Rajneesh K, Burghes AHM, Kolb SJ, Elsheikh B. Arnold WD, et al. Among authors: kelly k. BMJ Neurol Open. 2021 Aug 12;3(2):e000164. doi: 10.1136/bmjno-2021-000164. eCollection 2021. BMJ Neurol Open. 2021. PMID: 34466806 Free PMC article.
Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with Nusinersen.
Rich KA, Fox A, Yalvac M, Heintzman S, Tellez M, Bartlett A, Severyn S, Linsenmayer M, Kelly K, Reynolds J, Sterling GB, Weaver T, Rajneesh K, Pino MG, Arnold WD, Elsheikh B, Kolb SJ. Rich KA, et al. Among authors: kelly k. J Neuromuscul Dis. 2022;9(1):111-119. doi: 10.3233/JND-210735. J Neuromuscul Dis. 2022. PMID: 34776417
3,727 results